These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

256 related items for PubMed ID: 34433556

  • 21. Identification of a small-molecule RPL11 mimetic that inhibits tumor growth by targeting MDM2-p53 pathway.
    Wang B, Gao J, Zhao Z, Zhong X, Cui H, Hou H, Zhang Y, Zheng J, Di J, Liu Y.
    Mol Med; 2022 Sep 07; 28(1):109. PubMed ID: 36071402
    [Abstract] [Full Text] [Related]

  • 22. Acrolein preferentially damages nucleolus eliciting ribosomal stress and apoptosis in human cancer cells.
    Wang HT, Chen TY, Weng CW, Yang CH, Tang MS.
    Oncotarget; 2016 Dec 06; 7(49):80450-80464. PubMed ID: 27741518
    [Abstract] [Full Text] [Related]

  • 23. Notch1 signaling sensitizes tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in human hepatocellular carcinoma cells by inhibiting Akt/Hdm2-mediated p53 degradation and up-regulating p53-dependent DR5 expression.
    Wang C, Qi R, Li N, Wang Z, An H, Zhang Q, Yu Y, Cao X.
    J Biol Chem; 2009 Jun 12; 284(24):16183-16190. PubMed ID: 19376776
    [Abstract] [Full Text] [Related]

  • 24. A Panel of Genes Identified as Targets for 8q24.13-24.3 Gain Contributing to Unfavorable Overall Survival in Patients with Hepatocellular Carcinoma.
    Zhao K, Zhao Y, Zhu JY, Dong H, Cong WM, Yu Y, Wang H, Zhu ZZ, Xu Q.
    Curr Med Sci; 2018 Aug 12; 38(4):590-596. PubMed ID: 30128866
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. p53/mdm2 feedback loop sustains miR-221 expression and dictates the response to anticancer treatments in hepatocellular carcinoma.
    Fornari F, Milazzo M, Galassi M, Callegari E, Veronese A, Miyaaki H, Sabbioni S, Mantovani V, Marasco E, Chieco P, Negrini M, Bolondi L, Gramantieri L.
    Mol Cancer Res; 2014 Feb 12; 12(2):203-16. PubMed ID: 24324033
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Activation of the tumor suppressor p53 upon impairment of ribosome biogenesis.
    Bursac S, Brdovcak MC, Donati G, Volarevic S.
    Biochim Biophys Acta; 2014 Jun 12; 1842(6):817-30. PubMed ID: 24514102
    [Abstract] [Full Text] [Related]

  • 31. Nogo-B receptor promotes the chemoresistance of human hepatocellular carcinoma via the ubiquitination of p53 protein.
    Dong C, Zhao B, Long F, Liu Y, Liu Z, Li S, Yang X, Sun D, Wang H, Liu Q, Liang R, Li Y, Gao Z, Shao S, Miao QR, Wang L.
    Oncotarget; 2016 Feb 23; 7(8):8850-65. PubMed ID: 26840457
    [Abstract] [Full Text] [Related]

  • 32. Hepatitis B virus X protein promotes the stem-like properties of OV6+ cancer cells in hepatocellular carcinoma.
    Wang C, Wang MD, Cheng P, Huang H, Dong W, Zhang WW, Li PP, Lin C, Pan ZY, Wu MC, Zhou WP.
    Cell Death Dis; 2017 Jan 19; 8(1):e2560. PubMed ID: 28102846
    [Abstract] [Full Text] [Related]

  • 33. Oncogenic MYC Induces the Impaired Ribosome Biogenesis Checkpoint and Stabilizes p53 Independent of Increased Ribosome Content.
    Morcelle C, Menoyo S, Morón-Duran FD, Tauler A, Kozma SC, Thomas G, Gentilella A.
    Cancer Res; 2019 Sep 01; 79(17):4348-4359. PubMed ID: 31292158
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Icaritin promotes apoptosis and inhibits proliferation by down-regulating AFP gene expression in hepatocellular carcinoma.
    Li H, Liu Y, Jiang W, Xue J, Cheng Y, Wang J, Yang R, Zhang X.
    BMC Cancer; 2021 Mar 25; 21(1):318. PubMed ID: 33765973
    [Abstract] [Full Text] [Related]

  • 36. PICT-1 is a key nucleolar sensor in DNA damage response signaling that regulates apoptosis through the RPL11-MDM2-p53 pathway.
    Chen H, Han L, Tsai H, Wang Z, Wu Y, Duo Y, Cao W, Chen L, Tan Z, Xu N, Huang X, Zhuang J, Huang L.
    Oncotarget; 2016 Dec 13; 7(50):83241-83257. PubMed ID: 27829214
    [Abstract] [Full Text] [Related]

  • 37. Genomic gain/methylation modification/hsa-miR-132-3p increases RRS1 overexpression in liver hepatocellular carcinoma.
    Zhang X, Cong P, Tian L, Zheng Y, Zhang H, Liu Q, Wu T, Zhang Q, Wu H, Huang X, Xiong L.
    Cancer Sci; 2023 Nov 13; 114(11):4329-4342. PubMed ID: 37705317
    [Abstract] [Full Text] [Related]

  • 38. Novel CDK9 inhibitor oroxylin A promotes wild-type P53 stability and prevents hepatocellular carcinoma progression by disrupting both MDM2 and SIRT1 signaling.
    Yao JY, Xu S, Sun YN, Xu Y, Guo QL, Wei LB.
    Acta Pharmacol Sin; 2022 Apr 13; 43(4):1033-1045. PubMed ID: 34188177
    [Abstract] [Full Text] [Related]

  • 39. Correlation between expression of p53, p21/WAF1, and MDM2 proteins and their prognostic significance in primary hepatocellular carcinoma.
    Zhang MF, Zhang ZY, Fu J, Yang YF, Yun JP.
    J Transl Med; 2009 Dec 22; 7():110. PubMed ID: 20025780
    [Abstract] [Full Text] [Related]

  • 40. Knockdown of RRS1 by lentiviral-mediated RNAi promotes apoptosis and suppresses proliferation of human hepatocellular carcinoma cells.
    Wang J, Li Z, Zuo C, Xie Q, Li H, Jia J, Zhen Z, Qi R, Li Z, Liu D, Sun B.
    Oncol Rep; 2017 Oct 22; 38(4):2166-2172. PubMed ID: 28849112
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.